Literature DB >> 8592261

Fracture healing and mast cells.

K Banovac1, K Renfree, A L Makowski, L L Latta, R D Altman.   

Abstract

We analyzed the morphology and localization of mast cells during the course of fracture repair in control rats and in animals with delayed healing of fractures induced by nonsteroidal antiinflammatory drugs (NSAIDs). In the first 2 weeks of fracture healing in control animals, mast cells were found either in the vicinity of blood vessels or in the vascularized tissue proliferating into the cartilaginous portion of subperiosteal callus. In the later stages (6-8 weeks), mast cells were seen in loose connective tissue in bone marrow surrounded with translucent ground substance. At this stage of healing, a hyperplasia of mast cells and cell degranulation was often seen in close proximity to osteoclasts and areas of bone resorption. Treatment with NSAIDs delayed fracture healing and the appearance of mast cell hyperplasia in bone marrow for approximately 4 weeks, suggesting that mast cells have specifically defined temporal and regional distribution during the process of bone repair. Histochemical studies documented a significant amount of chymase in the mast cells in callus. This enzyme was purified from mast cells by chromatography and was able to digest in vitro proteins extracted from bone. Our data suggest that mast cells in fracture healing are involved in digestion of extracellular matrix in callus tissue that could facilitate (a) angiogenesis in the early stages of healing, and (b) the replacement of provisional tissue with newly formed bone in the later stages of fracture healing.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592261     DOI: 10.1097/00005131-199509060-00005

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  13 in total

1.  Bone healing in an aged murine fracture model is characterized by sustained callus inflammation and decreased cell proliferation.

Authors:  John H Hebb; Jason W Ashley; Lee McDaniel; Luke A Lopas; John Tobias; Kurt D Hankenson; Jaimo Ahn
Journal:  J Orthop Res       Date:  2017-10-09       Impact factor: 3.494

2.  Effects of experimental osteoporosis and low calcium intake on postextraction sockets of rats.

Authors:  Renata F D Prado; Vanessa Á S Silveira; Rosilene F D Rocha; Luana M R D Vasconcellos; Yasmin R Carvalho
Journal:  Int J Exp Pathol       Date:  2012-02-24       Impact factor: 1.925

Review 3.  Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.

Authors:  Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

4.  PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2-mediated arteriogenesis, mast cell accumulation, and fibrosis.

Authors:  Robinder S Dhillon; Chao Xie; Wakenda Tyler; Laura M Calvi; Hani A Awad; Michael J Zuscik; Regis J O'Keefe; Edward M Schwarz
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

5.  Teriparatide Treatment Improves Bone Defect Healing Via Anabolic Effects on New Bone Formation and Non-Anabolic Effects on Inhibition of Mast Cells in a Murine Cranial Window Model.

Authors:  Longze Zhang; Tao Wang; Martin Chang; Claire Kaiser; Jason D Kim; Tianyu Wu; Xiaoyi Cao; Xinping Zhang; Edward M Schwarz
Journal:  J Bone Miner Res       Date:  2017-07-19       Impact factor: 6.741

6.  The mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contractures.

Authors:  Michael J Monument; David A Hart; A Dean Befus; Paul T Salo; Mei Zhang; Kevin A Hildebrand
Journal:  J Bone Joint Surg Am       Date:  2010-06       Impact factor: 5.284

7.  The mast cell stabilizer ketotifen reduces joint capsule fibrosis in a rabbit model of post-traumatic joint contractures.

Authors:  Michael J Monument; David A Hart; A Dean Befus; Paul T Salo; Mei Zhang; Kevin A Hildebrand
Journal:  Inflamm Res       Date:  2011-12-16       Impact factor: 4.575

8.  Altered fracture repair in the absence of MMP9.

Authors:  Céline Colnot; Zachary Thompson; Theodore Miclau; Zena Werb; Jill A Helms
Journal:  Development       Date:  2003-09       Impact factor: 6.868

9.  Defective bone repair in mast cell-deficient Cpa3Cre/+ mice.

Authors:  Jose Luis Ramirez-GarciaLuna; Daniel Chan; Robert Samberg; Mira Abou-Rjeili; Timothy H Wong; Ailian Li; Thorsten B Feyerabend; Hans-Reimer Rodewald; Janet E Henderson; Paul A Martineau
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

10.  Controlling Arteriogenesis and Mast Cells Are Central to Bioengineering Solutions for Critical Bone Defect Repair Using Allografts.

Authors:  Ben Antebi; Longze Zhang; Dmitriy Sheyn; Gadi Pelled; Xinping Zhang; Zulma Gazit; Edward M Schwarz; Dan Gazit
Journal:  Bioengineering (Basel)       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.